Stocks and Investing
Stocks and Investing
Tue, December 1, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 30, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (ABBV) at Buy with Increased Target to $120 on, Nov 30th, 2020
Matthew Harrison of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $108 to $120 on, Nov 30th, 2020.
Matthew has made no other calls on ABBV in the last 4 months.
There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Matthew
- Gary Nachman of "BMO Capital" Initiated at Buy and Held Target at $123 on, Wednesday, November 18th, 2020
- Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $119 on, Monday, November 2nd, 2020
- Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $105 on, Wednesday, September 2nd, 2020
- David Risinger of "Morgan Stanley" Maintained at Buy with Increased Target to $108 on, Thursday, August 20th, 2020
- Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $127 on, Monday, August 3rd, 2020
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $111 on, Monday, August 3rd, 2020
Contributing Sources